CNSI Cambridge Neuroscience | Stock Discussion Forums

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
CNSI Cambridge Neuroscience

An SI Board Since July 1996

Posts	SubjectMarks	Bans	Symbol
675	9	0	CNSI

Emcee: Peter R Smith	Type: Unmoderated

Introduction Market Data Compact

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
650	Yeah, one of a handful of stinkers in my account, but you have to like the compa	Mike McFarland	-	5/20/2001
649	Responding for Mike, CeNeS is the name of the company, CEN.L is the London ticke	tom pope	-	5/19/2001
648	Subject 51221 fresh off of SI's drives, delivered straight to your thread.	scaram(o)uche	-	5/18/2001
647	Sipatrigine (BW619C89) eurostroke.org CPHAF was trading around 56 cents, CEN.	Mike McFarland	-	5/18/2001
646	unfortunately, the stock dropped 3p today (Thursday) in London	tom pope	-	4/5/2001
645	CeNeS releases upbeat year results Biopharma group says aims to break even in 20	smh	-	4/5/2001
644	Anybody notice the "pop" in CPHAF today? Symbol Market Last Sale Net	smh	-	4/3/2001
643	CPHAF--I have my shares now, quoted at 65 cents, up a nickle on 9200 shares to	Mike McFarland	-	3/14/2001
642	Mike, less than two years, stock was in brokerage name. I have a GTC to sell at	tom pope	-	3/9/2001
641	Hard to know whether this has to do with inefficient brokers, or something to d	Mike McFarland	-	3/8/2001
640	Mine showed up in my account at Merill at least a month ago	tom pope	-	3/8/2001
639	I contacted the company late last week at info@cambneuro.com and the answer I g	Mike McFarland	-	3/8/2001
638	Do you guys have your shares yet? This is what my broker sent me. Does this ma	limit	-	3/8/2001
637	BVF --> Merrill, Note on Feb 15, in The Guardian: Market professionals recko	Cheryl Galt	-	3/2/2001
636	Jan 26/01 --- CeNeS (LSE: CEN - news) said Phase II clinical trials of its morp	Cheryl Galt	-	3/2/2001
635	New CeNeS Drug Aims To Combat Substance Abuse 1/3/2001 Drugs Development And De	nigel bates	-	3/1/2001
634	received mine on Monday, Merrill Lynch	tom pope	-	2/15/2001
633	Have you guys received your shares yet?	limit	-	2/15/2001
632	<i>no, the london weather</i> Can't blame them for that.<g&g	nigel bates	-	2/14/2001
631	no, the london weather cheers Stefaan or was it the £ and he would have p	dalroi	-	2/14/2001
630	<i>I wonder what Lampert saw about CeNeS that he did not like?</i> T	nigel bates	-	2/14/2001
629	I'm asssuming that the BVF sales were shares that they received in Xchange f	tom pope	-	2/14/2001
628	That's a shame, I thought the new company looked pretty good, certainly more	Mike McFarland	-	2/14/2001
627	"...CeNeS Pharmaceuticals Plc (LSE: CEN.L - news) dropped 9-1/2p or 16 perc	nigel bates	-	2/14/2001
626	Nigel, thanks for reminding me. The new shares hit my account at Merrill on Mond	tom pope	-	2/14/2001

Go to reply# or date (mm/dd/yy):